Profile
Judy Chou is currently President, Chief Executive Officer & Director at AltruBio, Inc. since 2020.
Former positions include Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Director & Member-Governors Board at Biocom, Inc. from 2019 to 2020, and Senior Vice President & Global Head-Biotech at Bayer Pharmaceuticals.
Education includes a doctorate from Yale University.
Judy Chou active positions
| Companies | Position | Start |
|---|---|---|
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Chief Executive Officer | 2019-12-31 |
Former positions of Judy Chou
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 2025-12-08 |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Director/Board Member | 2020-11-18 |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Corporate Officer/Principal | - |
Training of Judy Chou
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
- Stock Market
- Insiders
- Judy Chou
















